Christer Tannergren - Concepedia

Author

Christer Tannergren

AstraZeneca (Sweden)ORCID

Also Known As

C Tannergren, C. Tannergren, Christer Tannergren

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (Sweden)Uppsala University Simulations Plus (United States)AstraZeneca (United Kingdom)Janssen (Belgium)

About

Christer Tannergren is an author at AstraZeneca (Sweden) specializing in medicine, pharmacology, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	20	1.3K
2	Biochemistry	5	5	186
3	Engineering	2	2	46
4	Public Health	2	2	63
5	Social Sciences	1	1	32

Christer Tannergren

Publications

Citations

H-Index

Page 1

	Year	Citations
ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO Niclas Petri, Christer Tannergren, Birgit Holst, Drug Metabolism and Disposition	2003	221
Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique Åsa Sjöberg, Mareike Lutz, Christer Tannergren, European Journal of Pharmaceutical Sciences Comprehensive StudyUssing Chamber TechniqueGastrointestinal PharmacologyMedicinePhysiology	2012	215
In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: Application of the mechanistic absorption model GI-Sim Erik Sjögren, Jan Westergren, Iain Grant, European Journal of Pharmaceutical Sciences Gastrointestinal Drug AbsorptionGastrointestinal PharmacologyMedicineBioanalysisGastroenterology	2013	167
Toward an Increased Understanding of the Barriers to Colonic Drug Absorption in Humans: Implications for Early Controlled Release Candidate Assessment Christer Tannergren, A. Bergendal, Hans Lennernäs, Molecular Pharmaceutics Substance AbuseCytochrome P450 3APermeability MarkersPharmacological StudyMedicine	2009	139
Transport Characteristics of Fexofenadine in the Caco-2 Cell Model Niclas Petri, Christer Tannergren, David Rungstad, Pharmaceutical Research Biophysical ModelingMembrane TransportTransport PhenomenaTransport CharacteristicsProtein Transport	2004	129
<i>In Silico</i> Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models Erik Sjögren, Helena Thörn, Christer Tannergren Molecular Pharmaceutics Gastrointestinal PharmacologyGastroenterologyIncomplete Gi AbsorptionDigestive TractPhysiologically-based Pharmacokinetic Modeling	2016	95
Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine, Christer Tannergren Clinical Pharmacology & Therapeutics	2003	88
The effect of ketoconazole on the <i>in vivo</i> intestinal permeability of fexofenadine using a regional perfusion technique Christer Tannergren, Tina W. Knutson, Lars Knutson, British Journal of Clinical Pharmacology	2003	74
Regional Intestinal Permeability of Three Model Drugs in Human David Dahlgren, Carl Roos, Anders Lundqvist, Molecular Pharmaceutics Gastrointestinal PharmacologyMedian PeffGastroenterologyThree Model DrugsDigestive Tract	2016	67
IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 2: An introduction to the simulation exercise and overview of results Alison Margolskee, Adam S. Darwich, Xavier Pépin, European Journal of Pharmaceutical Sciences Pharmacokinetic ModelingMedicineProcess Analytical TechnologyBiostatisticsSimulation Exercise	2016	66

Page 1